Director
Pfizer
Disclosure(s): Pfizer: employee, Stocks/Bonds (Public Company)
Jin Hyang Kim, Ph.D.in Immunology is Director of Clinical & Translational Biomarker at Pfizer. She is an accomplished, patient-centric drug developer, immunologist and registered pharmacist with over 16 years of dedicated experience in clinical biomarker research and translational strategy for inflammatory autoimmune and infectious diseases. Her career spans the Federal Government (CDC) as well as pharmaceutical and biotechnology companies, covering preclinical research and both early- and late-stage clinical development. She has a proven track record of overcoming complex challenges and delivering results, thanks to her strategic vision, scientific rigor, and attention to detail, as well as her people skills in dynamic, matrixed environments.